We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
POLY
1751
DELISTED
Plantronics, Inc.
POLY
| $532K | ﹤0.01% |
16,069
-301,539
| -95% | -$14.9M |
|
1752
Wave Life Sciences
WVE
$1.2B
| $531K | ﹤0.01% |
12,624
-1,204
| -9% | -$53.5K |
|
|
TWOU
1753
DELISTED
2U Inc
TWOU
| $530K | ﹤0.01% |
355
-345
| -49% | -$607K |
|
1754
Evolent Health
EVH
$447M
| $529K | ﹤0.01% |
+26,496
| New | +$613K |
|
|
SNR
1755
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $528K | ﹤0.01% |
+128,080
| New | +$674K |
|
1756
Xerox
XRX
$425M
| $527K | ﹤0.01% |
26,668
-330,528
| -93% | -$8.48M |
|
1757
AMC Entertainment Holdings
AMC
$2.31B
| $526K | ﹤0.01% |
+4,280
| New | +$701K |
|
1758
Constellium
CSTM
$3.99B
| $526K | ﹤0.01% |
+75,252
| New | +$670K |
|
1759
Mesa Laboratories
MLAB
$574M
| $525K | ﹤0.01% |
2,519
-1,304
| -34% | -$254K |
|
1760
Ionis Pharmaceuticals
IONS
$9.4B
| $522K | ﹤0.01% |
9,647
-2,959
| -23% | -$151K |
|
1761
Beazer Homes USA
BZH
$907M
| $519K | ﹤0.01% |
54,768
+42,070
| +331% | +$418K |
|
|
QADA
1762
DELISTED
QAD Inc.
QADA
| $519K | ﹤0.01% |
13,207
+1,736
| +15% | +$75.9K |
|
|
CHSP
1763
DELISTED
Chesapeake Lodging Trust
CHSP
| $518K | ﹤0.01% |
21,273
-5,029
| -19% | -$145K |
|
1764
Winnebago Industries
WGO
$909M
| $516K | ﹤0.01% |
21,316
-4,565
| -18% | -$121K |
|
|
QTS
1765
DELISTED
QTS REALTY TRUST, INC.
QTS
| $513K | ﹤0.01% |
13,848
-3,193
| -19% | -$127K |
|
|
BDN
1766
Brandywine Realty Trust
BDN
$554M
| $511K | ﹤0.01% |
39,725
-533
| -1% | -$7.53K |
|
1767
DMC Global
BOOM
$157M
| $511K | ﹤0.01% |
14,550
-110
| -0.8% | -$4K |
|
1768
Tenaris
TS
$26.8B
| $509K | ﹤0.01% |
23,873
-2,454
| -9% | -$68.1K |
|
1769
Anika Therapeutics
ANIK
$287M
| $508K | ﹤0.01% |
15,107
+177
| +1% | +$6.39K |
|
1770
Monro
MNRO
$398M
| $508K | ﹤0.01% |
+7,386
| New | +$540K |
|
1771
WesBanco
WSBC
$4B
| $508K | ﹤0.01% |
13,854
-6,789
| -33% | -$277K |
|
1772
Camden National
CAC
$976M
| $507K | ﹤0.01% |
14,091
-18,925
| -57% | -$759K |
|
|
FCB
1773
DELISTED
FCB Financial Holdings, Inc.
FCB
| $506K | ﹤0.01% |
15,061
| – | – |
|
|
FRC
1774
DELISTED
First Republic Bank
FRC
| $505K | ﹤0.01% |
5,808
-16
| -0.3% | -$1.46K |
|
|
SFLY
1775
DELISTED
Shutterfly, Inc.
SFLY
| $505K | ﹤0.01% |
12,548
-37,106
| -75% | -$1.95M |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.